Lupin informs about earnings conference call transcript

25 May 2021 Evaluate

Pursuant to Regulation 30(2) read with Schedule III Part A Para A (15) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lupin has informed that it enclosed a copy of the Transcript of the Q4 FY2021 Earnings Conference Call held on Thursday, May 13, 2021.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2342.00 10.25 (0.44%)
25-Mar-2026 09:44 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1771.40
Dr. Reddys Lab 1281.50
Cipla 1228.50
Zydus Lifesciences 897.50
Lupin 2342.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×